# Specific Safety Profile of Bevacizumab in Asian Patients With Advanced NSCLC

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/specific-safety-profile-of-bevacizumab-in-asian-patients-with-advanced-nsclc/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Zhenguang Chen,Beilong Zhong,Xueping Lun,Yingrong Lai,Amos Éla Bella,Weilin Yang,Jiabin Wu |
| Citations | 15 |
| DOI | 10.1097/md.0000000000000975 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://doi.org/10.1097/md.0000000000000975 |
| OpenAlex ID | https://openalex.org/W656206267 |
| PMID | 26091469 |
| Type | article |
| Year | 2015 |

## Paper authors

- [Jiabin Wu](https://scholariq.org/researchers/jiabin-wu/)

## Paper journal

- [Medicine](https://scholariq.org/journals/medicine/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Peptidase Inhibition and Analysis](https://scholariq.org/topics/peptidase-inhibition-and-analysis/)
- [Cholangiocarcinoma and Gallbladder Cancer Studies](https://scholariq.org/topics/cholangiocarcinoma-and-gallbladder-cancer-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.